Biotechnology - Mitsubishi Tanabe

Filter

Current filters:

Mitsubishi Tanabe

Popular Filters

Dezima Pharma in-licenses CETP inhibitor; Imaxio acquires Trolovol

22-01-2013

Netherlands-based biotech firm Dezima Pharma says it has in-licensed a cholesteryl ester transfer protein…

BiotechnologyCardio-vascularDEZ-001Dezima PharmaImaxioLicensingMitsubishi TanabeRare diseasesSpiroleptTrolovol

Back to top